Table: SymBio Pharmaceuticals - Q1 parent results

SymBio Pharmaceuticals

10/05/2018 07:30

May 10 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2018        Mar 31, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            888 mln             869 mln            4.20      
                 (+2.1 pct)         (+350.1 pct)       (+22.0 pct)  
  Operating     loss 714 mln        loss 525 mln        loss 2.98   
  Recurring     loss 748 mln        loss 583 mln        loss 3.04   
  Net           loss 759 mln        loss 582 mln        loss 3.06   
  EPS          loss 13.28 yen      loss 12.12 yen    loss 52.99 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T